We are live on ! Find out more
Pictet Asset Management

Pictet Asset Management Portfolio holdings

AUM $105B
1-Year Est. Return 38.07%
This Fund
S&P 500
This Quarter Est. Return
+2.76%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
10 Year Est. Return
AUM
$87.3B
AUM Growth
-$4.6B
Cap. Flow
-$5.51B
Cap. Flow %
-6.32%
Top 10 Hldgs %
18.42%
Holding
2,054
New
81
Increased
677
Reduced
810
Closed
85

Sector Composition

Rank Sector Weight
1 Technology 33.21%
2 Industrials 17.72%
3 Healthcare 13.34%
4 Consumer Discretionary 7.59%
5 Utilities 6.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLVM icon
401
Sylvamo
SLVM
$1.59B
$26.2M 0.03%
382,414
-21,051
-5% -$1.39M
NTAP icon
402
NetApp
NTAP
$38.8B
$26M 0.03%
201,721
+14,389
+8% +$1.62M
COF icon
403
Capital One
COF
$135B
$26M 0.03%
187,448
+21,817
+13% +$3.06M
OKE icon
404
Oneok
OKE
$57.6B
$25.8M 0.03%
316,676
+14,478
+5% +$1.16M
JAZZ icon
405
Jazz Pharmaceuticals
JAZZ
$16.2B
$25.5M 0.03%
238,921
-308,834
-56% -$34M
AJG icon
406
Arthur J. Gallagher & Co
AJG
$65.4B
$25.4M 0.03%
97,812
-2,241
-2% -$556K
OMC icon
407
Omnicom Group
OMC
$23.5B
$25.3M 0.03%
281,883
-15,375
-5% -$1.43M
KRYS icon
408
Krystal Biotech
KRYS
$9.72B
$25.2M 0.03%
137,433
-5,527
-4% -$928K
ASML icon
409
ASML
ASML
$686B
$25M 0.03%
24,450
-4,031
-14% -$3.88M
BNY
410
Bank of New York Mellon
BNY
$109B
$25M 0.03%
417,204
-26,741
-6% -$1.55M
CRH icon
411
CRH
CRH
$66.9B
$24.9M 0.03%
332,544
-666,370
-67% -$53.2M
EXPD icon
412
Expeditors International
EXPD
$23.1B
$24.8M 0.03%
198,915
-26,778
-12% -$3.19M
BNS icon
413
Scotiabank
BNS
$108B
$24.8M 0.03%
533,710
+8,941
+2% +$424K
ALKS icon
414
Alkermes
ALKS
$8.32B
$24.7M 0.03%
1,026,058
-1,703,073
-62% -$41.8M
LBPH
415
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$24.7M 0.03%
913,782
+337,106
+58% +$6.65M
MEDP icon
416
Medpace
MEDP
$16.9B
$24.6M 0.03%
59,745
-122,664
-67% -$48.6M
CNQ icon
417
Canadian Natural Resources
CNQ
$98.2B
$24.6M 0.03%
680,500
+5,354
+0.8% +$201K
NRIX icon
418
Nurix Therapeutics
NRIX
$2.72B
$24.5M 0.03%
1,173,518
+446,577
+61% +$6.95M
EOG icon
419
EOG Resources
EOG
$75.1B
$24.4M 0.03%
193,625
-1,124
-0.6% -$144K
GM icon
420
General Motors
GM
$78.5B
$24.3M 0.03%
523,943
-49,559
-9% -$2.24M
KNSA icon
421
Kiniksa Pharmaceuticals
KNSA
$6.07B
$24.3M 0.03%
1,303,716
-156,917
-11% -$2.94M
GPC icon
422
Genuine Parts
GPC
$18.7B
$24.3M 0.03%
175,865
-12,389
-7% -$1.85M
NSC icon
423
Norfolk Southern
NSC
$75.4B
$24.3M 0.03%
113,223
-29
-0% -$6.73K
AMP icon
424
Ameriprise Financial
AMP
$49.9B
$24.1M 0.03%
56,430
-3,273
-5% -$1.4M
MFC icon
425
Manulife Financial
MFC
$73.2B
$24M 0.03%
888,372
-692,415
-44% -$17.3M

Similar funds

Pictet Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, Pictet Asset Management held 2,054 positions worth $87.3B, down 5% from $91.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Pictet Asset Management withdrew a net $5.51B in Q2 2024, closing 85 positions and reducing 810 holdings. Its most notable exit was Immunocore, an estimated $45.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Pictet Asset Management opened a new position in iShares TIPS Bond ETF worth $35.1M.

  • Pictet Asset Management's largest Q2 2024 buy was iShares TIPS Bond ETF: 327,700 shares worth $35.1M.
  • Pictet Asset Management added most to Alphabet (Google) Class A in Q2 2024, an estimated $571M increase.
  • Pictet Asset Management's biggest Q2 2024 reduction was Alphabet (Google) Class C, cutting an estimated $881M.
  • Pictet Asset Management fully exited Immunocore in Q2 2024, selling an estimated $45.9M.
  • Pictet Asset Management's ten largest holdings make up 18% of its $87.3B portfolio in Q2 2024.
  • Pictet Asset Management opened 81 new positions and closed 85 in Q2 2024.
  • Pictet Asset Management's portfolio value fell 5% quarter-over-quarter to $87.3B.

Based on Pictet Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.